Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Analyst Ratings for Intellia Therapeutics
June 16, 2022
Tickers
NTLA
Tags
Benzinga
Market News
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2022
June 16, 2022
Tickers
AIRS
AJG
APLE
AWI
Tags
OMEX
SBH
IFF
From
Benzinga
Analyst Ratings for Intellia Therapeutics
May 24, 2022
Tickers
NTLA
Tags
Benzinga
Market News
NTLA
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
EDIT
^IXIC
CRSP
From
Motley Fool
10 Biggest Price Target Changes For Monday
May 09, 2022
Tickers
CI
EPAM
GH
K
Tags
Health Care Distributors
Price Target
SPCE
From
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Tickers
ABUS
AGIO
ALDX
ARGX
Tags
News
CHRS
DSKYF
From
Benzinga
Earnings Preview For Intellia Therapeutics
May 04, 2022
Tickers
NTLA
Tags
Earnings
Benzinga
Market News
From
Benzinga
How To Attend Intellia Therapeutics Q1 2022 Earnings Conference Call
May 02, 2022
Tickers
NTLA
Tags
BZI/CONF
Market News
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 28, 2022
April 28, 2022
Tickers
ACHR
ALL
AM
ARVN
Tags
VBLT
PEBO
CLBK
From
Benzinga
4 Analysts Have This to Say About Intellia Therapeutics
April 28, 2022
Tickers
NTLA
Tags
Benzinga
Market News
NTLA
From
Benzinga
Stocks That Hit 52-Week Lows On Thursday
April 21, 2022
Tickers
HLBZ
HNST
HYFM
HYRE
Tags
NRXP
SEEL
RSI
From
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
Tickers
ACLX
ADVM
AFCG
ALLK
Tags
EE
BMEA
GURE
From
Benzinga
3 Top Biotech Stocks Ready for a Bull Run
April 20, 2022
Tickers
BNTX
NTLA
PFE
REGN
Tags
REGN
PFE
SNY
From
Motley Fool
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
NTLA
Recent Press Releases
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
EDIT
CRSP
VRTX
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
GS
SFIX
CRSP
From
Motley Fool
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
Market News
BLUE
NTLA
From
Benzinga
Here's How Much $100 Invested In Intellia Therapeutics 5 Years Ago Would Be Worth Today
March 15, 2022
Tickers
NTLA
Tags
Earnings
Benzinga
NTLA
From
Benzinga
Intellia's CRISPR-Engineered Cell Therapy Receives FDA Orphan Drug Tag For Bone Marrow Cancer
March 10, 2022
Tickers
NTLA
Tags
General
FDA
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2022
March 07, 2022
Tickers
AAL
AU
AUGX
AZUL
Tags
PVH
BMO
C
From
Benzinga
63 Biggest Movers From Yesterday
March 04, 2022
Tickers
AEO
ANGH
APCX
ATNX
Tags
BDR
Movers From Yesterday
MNSO
From
Benzinga
Is Intellia a Good Gene-Editing Stock to Buy Now?
March 03, 2022
Tickers
NTLA
REGN
Tags
REGN
Recent Press Releases
NTLA
From
Motley Fool
Can Biotech Stocks Provide Crypto-Like Growth for Your Portfolio?
March 03, 2022
Tickers
BNTX
BTC
CRSP
ETH
Tags
CRSP
Recent Press Releases
NTLA
From
Motley Fool
80 Biggest Movers From Yesterday
March 02, 2022
Tickers
ALBO
AMBA
AMLX
ANPC
Tags
MULN
FRPT
NRSN
From
Benzinga
44 Stocks Moving In Tuesday's Mid-Day Session
March 01, 2022
Tickers
AMBA
AREB
ATRA
ATXI
Tags
LCID
DSS
HRTX
From
Benzinga
Analyst Ratings For Intellia Therapeutics
March 01, 2022
Tickers
NTLA
Tags
NTLA
Market News
Benzinga
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
News
AVID
EPZM
From
Benzinga
Intellia Shares Updated Data On Gene Editing Durability In Rare Disease
March 01, 2022
Tickers
NTLA
REGN
Tags
General
Movers
Biotech
From
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 28, 2022
Tickers
ATXI
BIMI
CKPT
FGEN
Tags
Market News
GBS
BZI/TFM
From
Benzinga
This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility
February 28, 2022
Tickers
AMZN
ARKK
BLL
COIN
Tags
U
LRCX
INNO
From
MarketWatch
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.